| Literature DB >> 25180702 |
Catherine Sherrington1, Stephen R Lord2, Constance M Vogler3, Jacqueline C T Close4, Kirsten Howard5, Catherine M Dean6, Gillian Z Heller7, Lindy Clemson8, Sandra D O'Rourke2, Elisabeth Ramsay2, Elizabeth Barraclough2, Robert D Herbert2, Robert G Cumming5.
Abstract
BACKGROUND: Home exercise can prevent falls in the general older community but its impact in people recently discharged from hospital is not known. The study aimed to investigate the effects of a home-based exercise program on falls and mobility among people recently discharged from hospital. METHODS ANDEntities:
Mesh:
Year: 2014 PMID: 25180702 PMCID: PMC4152130 DOI: 10.1371/journal.pone.0104412
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Participant flow.
Baseline characteristics of participants.
| Characteristic | Control (n = 169) | Intervention (n = 171) |
| Age, mean (SD) years | 80.8 (8.2) | 81.6 (7.8) |
| Hospital length of stay, mean (SD) days | 15.6 (15.7) | 17.0 (19.3) |
| Mini Mental State Examination score, mean (SD)/30 | 28.0 (1.8) | 27.9 (2.0) |
| Females, n (%) | 128 (76) | 123 (72) |
| 1 or more falls in previous 12 months, n (%) | 117 (69) | 123 (72) |
| Medications, mean (SD) number | 7.5 (3.3) | 7.5 (3.3) |
| Psychotropic medication, n (%) | 30 (18) | 17 (10) |
| Benzodiazepine medication, n (%) | 31 (18) | 20 (12) |
| Living in low-care residential facility (hostel), n (%) | 12 (7) | 8 (5) |
| Co-morbidities, mean (SD) number | 6.9 (2.7) | 7.2 (2.9) |
| Primary diagnosis on admission (from medical file) n (%) | ||
| Lower limb fracture | 24 (14) | 26 (15) |
| Upper limb fracture | 7 (4) | 7 (4) |
| Vertebral fracture | 9 (5) | 12 (7) |
| Respiratory illness | 13 (8) | 11 (6) |
| Infection | 13 (8) | 13 (8) |
| Fall and soft tissue damage | 15 (9) | 19 (11) |
| Neurological condition | 2 (1) | 4 (2) |
| Musculoskeletal condition | 21 (12) | 19 (11) |
| Cerebrovascular disease | 4 (2) | 4 (2) |
| Ischaemic heart disease | 3 (2) | 2 (1) |
| General medical conditions | 11 (7) | 12 (7) |
| General symptoms | 14 (8) | 12 (7) |
Primary mobility outcomes and secondary outcomes.
| Control | Intervention | Difference between groups (baseline adjusted) | ||||||
| Baseline, n = 169 | 3 month, n = 137 | 12 month, n = 155 | Baseline, n = 171 | 3 month, n = 156 | 12 month, n = 157 | 3month mean (95% CI), p | 12 month mean (95% CI), p | |
|
| ||||||||
| Summary Performance Score (primary outcome), 0–3, mean (SD) | 1.92 (0.48) | 1.98(0.53) | 1.94(0.56) | 1.92 (0.46) | 2.05(0.48) | 2.06(0.52) |
|
|
| Mobility task ease over 12 months (primary outcome), 0–40, mean (SD) | 28.2 (7.2) | 27.7 (6.7), n = 156 | 27.6 (6.7) | 28.2 (6.0), n = 159 | 0.49, 95% CI −0.91 to 1.90, p = 0.488 | |||
| Short Physical Performance Battery, 0–12, mean (SD) | 6.73 (2.84) | 7.14 (2.96) | 6.89 (1.92) | 6.72 (2.73) | 7.48(2.94) | 7.41(2.02) |
|
|
| Sit to stand, stands/sec, mean (SD) | 0.22(0.16) | 0.23 (0.16) | 0.22 (0.2) | 0.22 (0.16) | 0.26(0.17) | 0.28 (0.2) | 0.02 (−0.009 to 0.04), p = 0.211 |
|
| Gait speed, m/sec, mean (SD) | 0.72 (0.3) | 0.74 (0.32) | 0.76(0.32) | 0.74 (0.3) | 0.75(0.30) | 0.77(0.31) | −0.007 (−0.05 to 0.049), p = 0.978 | −0.011 (−0.06 to 0.04), p = 0.662 |
| Standing Balance, sec, 0–30, mean (SD) | 23.3 (7.1) | 24.1 (7.7) | 23.4 (8.3) | 22.9(7.4) | 24.9 (7.0) | 24.4 (7.5) | 1.04 (−0.36 to 2.44), p = 0.144 | 1.18 (−0.30 to 2.7), p = 0.117 |
| Single leg stance time, sec, 0–10, mean (SD) | 2.2 (3.7) | 3.0 (4.1) | 3.0 (4.1) | 2.2 (3.8) | 3.5 (4.2) | 3.2 (4.3) | 0.32 (−0.42 to 1.07), p = 0.389 | 0.15 (−0.56 to 0.87), p = 0.677 |
| Maximum Balance Range, mm, mean (SD) | 115.49(40.91) | 114.94(47.3) | 115.8(47.6) | 111.19(41.87) | 120.7(47.0) | 122.5(50.3) |
|
|
| Coordinated Stability, score, mean (SD) | 21.77(12.64) | 19.9 (13.2) | 21.7 (15.3) | 24.44 (13.82) | 22.78(13.7) | 22.8 (13.6) | 0.76 (−1.44 to 2.95), p = 0.498 | −0.395 (−2.81 to 2.02), p = 0.747 |
| Step Test, steps, mean (SD) | 7.4 (4.9) | 8.5 (5.4) | 7.9 (5.9) | 7.4 (4.8) | 8.9 (5.3) | 8.7 (6.0) | 0.36 (−0.36 to 1.09), p = 0.329 | 0.69 (−0.14 to 1.51), p = 0.101 |
| Steps required to turn 180 degrees, mean (SD) | 5.6(1.8) | 5.5(1.9) | 5.6(2.2) | 5.9(2.6) | 5.3(1.7) | 5.3(2.3) | −0.29 (−0.64 to 0.06) p = 0.110 |
|
|
| ||||||||
| PPA Score, mean (SD) | 1.20 (1.41) | 1.41 (1.59) | 1.59 (1.64) | 1.37 (1.49) | 1.42 (1.50) | 1.61 (1.75) | −0.14 (−0.40 to 0.11), p = 0.269 | − 0.45 (−0.32 to 0.23), p = 0.745 |
| Postural sway on foam total length, mean (SD) | 157.5(99.5) | 168.6(101.1) | 180.1(107.9) | 170.4 (99.5) | 161.9(93.7) | 167.3(100.0) |
|
|
| Knee extension strength, kg, mean (SD) | 14.6 (6.1) | 13.2 (6.1) | 13.3(5.8) | 14.6 (6.4) | 13.8 (7.0) | 14.0(6.8) | 0.20 (−1.00 to 1.39), p = 0. 745 | 0.61 (−0.49 to 1.72), p = 0.275 |
| Hand Reaction time, msec, mean (SD) | 310.9 (104.6) | 333.7(146.1) | 334.3(132.7) | 307.5 (108.1) | 318.3(122.2) | 346.9(149.3) | −11.82 (−38.82 to 15.17), p = 0.389 | 17.48 (−11.25 to 46.20), p = 0.232 |
| Choice Stepping reaction time, step/sec, mean (SD) | 0.20 (0.13) | 0.22 (0.14) | 0.21 (0.2) | 0.20 (0.13) | 0.23 (0.15) | 0.22 (0.2) | 0.01 (−0.02 to 0.03), p = 0.591 | 0.01 (−0.02 to 0.03), p = 0.585 |
|
| 20.4 (8.2) | 19.99 (8.83) | 19.05(7.99) | 20.8 (8.9) | 20.92 (8.91) | 19.61(8.67) | 0.48 (−5.07 to 1.40), p = 0.337 | 0.37 (−0.58 to 1.33), p = 0.444 |
|
| 24.53 (9.54) | 26.15(10.68) | 24.98(9.62) | 25.09 (10.49) | 25.21(11.26) | 25.08(10.99) | −1.19 (−3.74 to 1.36), p = 0.359 | 0.014 (−2.29 to 2.33), p = 0.991 |
|
| ||||||||
| Health compared with past 12 months, n (%) | OR 1.11, (0.72 to 1.72), p = 0.642 |
| ||||||
| Better | 46 (27) | 38 (28) | 37 (24) | 30 (18) | 44 (29) | 60 (38) | ||
| Much the same | 69 (41) | 48 (35) | 69 (45) | 59 (35) | 50 (33) | 60 (38) | ||
| Worse | 54 (32) | 50 (37) | 49 (32) | 82 (48) | 59 (39) | 37 (24) | ||
| EQ5D utility score, mean (SD) | 0.62(0.23) | 0.60(0.33) | 0.63(0.23) | 0.66(0.27) | 0.04, −0.02 to 0.10 p = 0.229 | |||
| SF12 Physical Component, mean (SD) | 38.17 (8.36) | 40.32 (9.04) | 39.27 (9.26) | 37.44 (8.90) | 40.10 (8.53) | 40.37 (8.29) | −0.10 (−1.83 to 1.64), p = 0.914 |
|
| SF12 Mental Component, mean (SD) | 54.70 (6.79) | 54.18 (7.01) | 55.19 (7.09) | 54.71 (6.49) | 55.31 (6.37) | 55.87 (5.02) | 1.06 (−0.38 to 2.5), p = 0.149 | 0.70 (−0.59 to 1.99), p = 0.288 |
| SF6D utility score, mean (SD) | 0.67 (0.10) | 0.69 (0.12) | 0.70 (0.12) | 0.66 (0.10) | 0.70 (0.11) | 0.71 (0.11) | 0.01 (−0.01 to 0.03), p = 0.346 |
|
|
| 11.56 (4.18) | 11.97 (3.82) | 13.14(4.87) | 11.70 (4.09) | 11.69 (3.94) | 12.57 (4.22) | −0.31 (−1.03 to 0.41), p = 0.393 | −0.52 (−1.40 to 0.36), p = 0.243 |
|
| 5.5 (6.7) | 3.6 (6.1) | 4.5 (5.0) | 3.1 (7.4) | IRR 1.09 (0.85 to 1.40), p = 0.482 | |||
|
| 37.3 (43.2) | 24.7 (37.5) | 40.2(42.9) | 25.3 (36.9) | IRR 0.91 (0.62 to 1.33), p = 0.631 | |||
|
| 41.4 (7.4) | 38.7 (10.3) | 41.5 (7.3) | 40.5 (8.6) |
| |||
|
| 5.9(7.3) | 7.6 (10.3) | 6.0(8.2) | 5.8 (8.3) | 6.2 (8.0) | 7.5 (9.7) | 0.91 (0.69 to 1.18), p = 0.459 |
|
|
| ||||||||
| Total Physical Activity Score, hours/week | 18.13 (11.56) | 26.26(15.74) | 29.29(21.07) | 18.5 (12.98) | 27.34(16.34) | 30.89(20.11) | 0.59 (−2.46 to 3.64), p = 0.703 | 1.05 (−2.89 to 4.99), p = 0.600 |
| Home Exercise, hours/week | 0.15 (0.33) | 0.71 (1.30) | 0.45 (0.98) | 0.22 (0.47) | 0.87 (1.51) | 0.81 (1.40) | 0.10 (−0.22 to 0.42), p = 0.521 |
|
Higher scores reflect better performance.
Lower scores reflect better performance.
Between group differences are from linear regression models with change score (final minus initial) score as the dependent variable and group allocation and baseline performance on that item as independent variables.
Between group differences are from linear regression models with follow-up score as the dependent variable and group allocation and baseline performance on that item as independent variables.
Between group differences are from ordinal regression models with follow-up score as the dependent variable and group allocation and baseline performance on that item as independent variables.
Between group differences are from negative binomial regression models with the total number of events as the dependent variable and group allocation and number of events at baseline as independent variables.
some participants unable to be assessed due to knee pain or skin problems; data available for 168 per group at baseline; 3 months 131 control, 152 intervention;12 months 151 control, 156 intervention.
Bold indicates p<0.05 for between group differences. Italics indicate p<0.1 for between group differences.
Intervention dose prescribed and adherence over the 12 month study period.
| Time point | Participants who agreed to exercise, number (% of 171) | Exercise sessions agreed to, median (range) | Different exercises prescribed, median (range) | Exercise repetitions agreed to per session, mean (SD) | Participants who actually exercised, number (% of 171) | Exercise sessions completed, median (range) | Physiotherapist's estimate of % prescribed exercise completed, mean (SD) | Physiotherapist's estimate of number of exercise repetitions completed, mean (SD) |
| Month 1 | 162 (95%) | 6 (0 to 7) | 5 (0 to 8) | 59 (39) | 153 (90%) | 5 (0 to 7) | 77 (34) | 266 (227) |
| Month 3 | 151 (88%) | 5 (0 to 7) | 6 (0 to 9) | 93 (65) | 138 (81%) | 4 (0 to 7) | 64 (38) | 391 (396) |
| Month 8 | 130 (76%) | 3 (0 to 7) | 6 (0 to 9) | 77 (70) | 113 (66%) | 3 (0 to 7) | 51 (43) | 289 (352) |
| Month 12 | 121 (71%) | 3 (0 to 7) | 5 (0 to 10) | 72 (71) | 103 (60%) | 3 (0 to 7) | 47 (43) | 250 (335) |
Falls outcomes.
| Control (n = 169) | Intervention (n = 171) | Difference between groups | |
| Falls per participant, n (%) | |||
| 0 | 99 (59) | 73 (43) | 1.38 (1.11 to 1.73), p = 0.004 |
| 1 | 45 (27) | 58 (34) | |
| 2 | 12 (7) | 16 (9) | |
| 3 | 4 (2) | 13 (8) | |
| ≥4 | 9 (5) | 11 (6) | |
| All falls (primary outcome) | 123 | 177 | 1.43 (1.07 to 1.93), p = 0.017 |
| Fall location | |||
| Indoors | 79 | 128 | 1.62 (1.13 to 2.33), p = 0.009 |
| Outdoors | 44 | 49 | 1.10 (0.71 to 1.69), p = 0.670 |
| Falls with injuries | |||
| Received health care | 53 | 61 | 1.14 (0.76 to 1.73), p = 0.524 |
| Fractures | 15 | 14 | n/a |
| Falls by time period | |||
| Months 0–3 | 27 | 44 | 1.61 (0.98 to 2.65), p = 0.061, n = 340 |
| Months 4–6 | 19 | 49 | 2.56 (1.42 to 4.62), p = 0.002, n = 337 |
| Months 7–9 | 27 | 25 | 0.92 (0.52 to 1.62), p = 0.774, n = 327 |
| Months 9–12 | 50 | 59 | 1.16 (0.75 to 1.78), p = 0.503, n = 323 |
| Participant reported cause of fall | |||
| Lost balance | 50 | 77 | |
| Legs gave way | 11 | 14 | |
| Trip | 35 | 58 | |
| Slip | 14 | 17 | |
| Other | 13 | 11 | |
| Falls by gait subgroup | |||
| ≥ 0.73 m/s at baseline | 80 | 85 | 1.95 (1.28 to 2.99), p = 0.002, n = 167 |
| <0.73 m/s at baseline | 43 | 92 | 1.15 (0.76 to 1.75), p = 0.498, n = 173 |
Relative risk, 95% confidence interval and p value from modified Poisson regression model for the proportion of participants who had one or more falls in the 12 month follow up period in the intervention group compared to the control group.
Incidence rate ratio, 95% confidence interval and p value from negative binomial regression model comparing the number of falls in the 12 month follow up period in the intervention group compared to the control group.
Incidence rate ratio not calculated due to small numbers.
Figure 2Number of falls in the 12-month study period by baseline walking velocity and group.
The lines shown are locally weighted regression lines using Stata's “lowess” command.